Prognostic value of thallium 201 myocardial scintigraphy with dipyridamole before peripheral arterial surgery;Valeur pronostique de la tomoscintigraphie myocardique au thallium-201 sensibilisée au dipyridamole avant chirurgie artérielle périphérique

Archives des Maladies du Coeur et des Vaisseaux

Volumn 96, Issue 4, 2003, Pages 281-287

  Vaquette, B ^a   Clergues, F ^b   Kalangos, A ^b   Dorsaz, P A ^b   Righetti, A ^b  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; THALLIUM 201;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; CORONARY RISK; FEMALE; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART PERFUSION; HEART SCINTISCANNING; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PREOPERATIVE CARE; PROGNOSIS; STRESS ECHOCARDIOGRAPHY; SURGICAL RISK; TOMOSCINTIGRAPHY;

EID: 0037652297     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Eagle KA, Berger PB, Calkins H et al. ACC/AHA Guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary. A report of the American College of Cardiology/American Heart association Task Force on practice guidelines (committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). JACC 2002; 39: 542-53.
2. Hertzer NR. Basic data concerning associated coronary disease in peripheral vascular patients. Ann Vasc Surg 1987; 1: 616-20.
3. Gersh BJ, Rihal CS, Rooke TW, Ballard DJ. Evaluation and management of patients with both peripheral vascular and coronary artery disease. J Am Coll Cardiol 1991; 18: 203-14.
4. Hertzer NR, Beven EG, Young JR et al. Coronary artery disease in peripheral vascular patients: a classification of 1 000 coronary angiograms and results of surgical management. Ann Surg 1984; 199: 223-33.
5. Eagle KA, Rihal CS, Mickel MC, Holmes DR, Foster ED, Gersh BJ. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3 368 operations. Circulation 1997; 96: 1882-7.
6. Hassan SA, Hlatky MA, Boothroyd DB et al. Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Med 2001; 110: 260-6.
7. Eagle KA, Coley CM, Newell JB et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989; 110: 859-66.
8. Furber A, Berdague P, Cadiou C et al. Recommandations de la Société française de cardiologie concernant la pratique des épreuves de provocation d'ischémie en cardiologie nucléaire chez l'adulte. Arch Mal Cœur 2000; 93: 1309-32.
9. Leppo JA, Dahlberg ST. The question: to test or not to test in preoperative cardiac risk evaluation. J Nucl Cardiol 1998; 5: 332-42.
10. Mangano DT, Browner WS, Hollenberg M, Li J, Tateo IM. Long-term cardiac prognosis following noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA 1992; 268: 233-9.
11. Shaw LJ, Eagle KA, Gersh BJ, Miller DD. Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. J Am Coll Cardiol 1996; 27: 787-98.
12. Schneider JF, Thomas HE, Kreger BE, McNamara PM, Kannel WB. Newly acquired left bundle-branch block: the Framingham study. Ann Intern Med 1979; 90: 303-10.
13. Hesse B, Diaz LA, Snader CE, Blackstone EH, Lauer MS. Complete bundle branch block as an independent predictor of all-cause mortality: report of 7 073 patients referred for nuclear, exercise testing. Am J Med 2001; 110: 253-9.
14. Boucher CA, Brewster DC, Darling RC, Okada RD, Strauss HW, Pohost GM. Determination of cardiac risk by dipyridamolethallium imaging before peripheral vascular surgery. N Engl J Med 1985; 312: 389-94.
15. L'Italien GJ, Paul SD, Hendel RC et al. Development and validation of a Bayesian model for perioperative cardiac risk assessment in a cohort of 1 081 vascular surgical candidates. J Am Coll Cordial 1996; 27: 779-86.
16. Lette J, Waters D, Cerino M, Picard M, Champagne P, Lapointe J. Preoperative coronary artery disease risk stratification based on dipyridamole imaging and a simple three-step, three-segment model for patients undergoing noncardiac vascular surgery or major general surgery. Am J Cardiol 1992; 69: 1553-8.
17. Younis LT, Miller DD, Chaitman BR. Preoperative strategies to assess cardiac risk before non cardiac surgery. Clin Cardiol 1995; 18: 447-54.
18. Iskandrian AS, Heo J, Kong B, Lyons E. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients. J Am Coll Cardiol 1989; 14: 1477-86.
19. Lette J, Tatum JL, Fraser S et al. Safety of dipyridamole testing in 73 806 patients: the Multicenter Dipyridamole Safety Study. J Nucl Cardiol 1995; 2: 3-17.
20. Gottlieb A, Banoub M, Sprung J, Levy PJ, Beven M, Mascha EJ. Perioperative cardiovascular morbidity in patients with coronary artery disease undergoing vascular surgery after percutaneaaus transluminal coronary angioplasty. J Cardiothorac Vasc Anesth 1998; 12: 501-6.